Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (657)	3/11/2002 9:24:08 AM
From: nigel bates	Respond to of 1005

More grist for the mill - SAN DIEGO, March 11 /PRNewswire/ -- MitoKor announced today that it has filed a registration statement with the Securities and Exchange Commission for a proposed initial public offering of its common stock. All of the offered shares will be sold by MitoKor. The underwriters for the offering will be RBC Capital Markets, Lazard, Legg Mason Wood Walker Incorporated and Gerard Klauer Mattison. MitoKor is focused on the discovery and development of drugs for the treatment of major diseases and conditions associated with mitochondrial dysfunction. Management intends to use the net proceeds of the offering for working capital and other general corporate purposes, including potential acquisitions of products, technologies or companies... Worth keeping an eye on, possibly. nig